@DoctorJSpicer Profile picture

Jonathan Spicer MD PhD

@DoctorJSpicer

Medical Director of the McGill Thoracic Oncology Program; Chest surgeon; Neutrophil biologist; Cancer immunologist; Aspiring farmer

Similar User
Fred R. Hirsch photo

@fred_hirsch

donington photo

@jdoningtonmd

Joshua Reuss photo

@Joshua_Reuss

Patrick Forde photo

@FordePatrick

Hossein Borghaei, DO photo

@HosseinBorghaei

Elliot Servais, MD, FACS photo

@ElliotServaisMD

Corey Langer photo

@CoreyLangerMD

IASLC photo

@IASLC

Dr. Julie Brahmer photo

@JulieBrahmer

Charu Aggarwal, MD, MPH, FASCO photo

@CharuAggarwalMD

Sai-Hong Ignatius Ou photo

@oncoOuLungCA

Eric Lim photo

@ekslim

Dipesh Uprety MD FACP photo

@DipeshUpretyMD

JTO & JTO CRR photo

@JTOonline

Johns Hopkins Thoracic Oncology photo

@HopkinsThoracic

Pinned

KN671 OS and HRQoL! Check it out: sciencedirect.com/science/articl…

Tweet Image 1

Jonathan Spicer MD PhD Reposted

Not even published and already presented by @filippog92

Tweet Image 1

Jonathan Spicer MD PhD Reposted

Check out the agenda for our next roundtable on early #NSCLC with Jean Yannis Perentes, @SalmaJabbour1, @DoctorJSpicer and @MartinReck2! ⏰ 26th November at 5PM CET Join and share your insights or questions for free ⬇️


Jonathan Spicer MD PhD Reposted

I am very excited to moderate this timely discussion on lobe vs sublobar resection for #lungcancer with these 3 thoracic surgeon experts! Please join us Nov 6, 8pm EST Link in the Tweet below @TomVargheseJr @BrendonStilesMD @maraantonoff @DavidCookeMD @TOutcomes @DoctorJSpicer

This post is unavailable.

If you come train in thoracic surgery @MThoracics or want to do thoracic oncology research with our team @RIMUHC1, it’s worth noting that there is an excellent BBQ training component to the program! Please consider applying or reach out to our new program director @RousseauMC!

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Jonathan Spicer MD PhD Reposted

Here’s a reminder from the inclusion criteria that in SABRTooth patients had to be deemed “at higher risk for surgical complications” by MDT.

Tweet Image 1

Jonathan Spicer MD PhD Reposted

To help members navigate the current treatment options available for pts w/resectable #LungCancer, the #IASLC convened a global multidisciplinary expert panel to review data & provide guidelines/flow charts to select the optimal regimen for their patient. bit.ly/3LwKQiW

Tweet Image 1

Jonathan Spicer MD PhD Reposted

I am at the #acs2024 meeting today. Lots of discussion at various talks about implementing robotic surgery technologies for a variety of operations. To me, much of this didn’t make sense. Robotic appendectomy? Really? Surgeons need to keep in mind that robotic technologies…

Physician conversion factors: 2000: $36.6173 2003: $36.7856 2006: $37.8975 2009: $36.0666 2012: $34.0376 2015: $35.7547 2018: $35.9996 2021: $34.8931 2024: $32.7442 UHC stock up 8,556% Insurance premiums up 342% Inflation up 86% Physician pay down 10% We should keep cutting…

Tweet Image 1


Jonathan Spicer MD PhD Reposted

First report of response to tarlatamab in a patient with atypical carcinoid @JTOonline Multiple prior lines of therapy - tumor had high DLL3 expression and mounted a response to this DLL3 BiTE. jtocrr.org/article/S2666-…


Jonathan Spicer MD PhD Reposted

Researchers in China recently found that CT-based imaging models (radiomics and DNNs) can accurately identify the spread through air spaces status of clinical-stage T1N0 lung adenocarcinoma. See what this means for future patient outcomes in #JTCVS Open: doi.org/10.1016/j.xjon…

Tweet Image 1

Jonathan Spicer MD PhD Reposted

@jdoningtonmd giving her expert review of immunotherapy trials in NSCLC “I’m not trying to compare the trials, I’m telling you that the trials are all the same.” With some important subtleties…(thread)

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Jonathan Spicer MD PhD Reposted

Absolutely wonderful McGill upper gastrointestinal cancer symposium. Fantastic programme organised by @LFerri123 My great honour to present the exciting work on surveillance within the @SARONG_Trial! @NDSurgicalSci @SITU_Oxford

Tweet Image 1

Jonathan Spicer MD PhD Reposted

@mivanbh⁩ from Amsterdam presenting in the finer points of Robotic esophagectomy at the 7th annual McGill Upper GI cancer symposium. ⁦@cusm_muhc⁩ ⁦@McGillMed

Tweet Image 1

Jonathan Spicer MD PhD Reposted

So it begins! Prasad Iyer kicking off ⁦the 7th upper GI cancer symposium ⁦@mcgillu⁩ in ⁦@Montreal

Tweet Image 1

Jonathan Spicer MD PhD Reposted

An interesting article, "Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach?" - The Journal of Thoracic and Cardiovascular Surgery buff.ly/3zY8qD1

Tweet Image 1

Jonathan Spicer MD PhD Reposted

Online First: #Perioperative #chemotherapy and #nivolumab in non-small-cell #lungcancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial #NSCLC thelancet.com/journals/lanon…


Jonathan Spicer MD PhD Reposted

6y of minimally invasive lung resections at @MThoracics Impressive short terms outcomes, especially for advanced procedures. Waiting for the complete results! @DoctorJSpicer @LFerri123 @sara_najmeh @JonathanCools @ronirayes

So very proud of our team’s accomplishments in minimally invasive lung resection @MThoracics @mcgillsurgery @cusm_muhc @filippog92 presented our results on lobectomy and extended lobectomy for #NSCLC at #ITSOS24 @AATSHQ: 85% VATS; 3.3% conversion; 0.1% 30-day mortality; 6.8%…

Tweet Image 1


Jonathan Spicer MD PhD Reposted

‼️Important NICE approvals‼️ ✅ ALINA: adjuvant alectinib ✅ KN-671: peri-operative pembrolizumab 👍 This is good news for lung cancer patients in England & Wales Check your @BTOGORG eNews for details

Tweet Image 1

Jonathan Spicer MD PhD Reposted

Amazing news: #KN671 approved in England & Wales today 🎯 #perioperative Pembrolizumab for patients with #lungcancer is now an option! @DoctorJSpicer @FordePatrick @DrJNaidoo @BTOGORG #LCSM @RuthStraussFdn @Roy_Castle_Lung @IASLC

‼️Important NICE approvals‼️ ✅ ALINA: adjuvant alectinib ✅ KN-671: peri-operative pembrolizumab 👍 This is good news for lung cancer patients in England & Wales Check your @BTOGORG eNews for details

Tweet Image 1


So very proud of our team’s accomplishments in minimally invasive lung resection @MThoracics @mcgillsurgery @cusm_muhc @filippog92 presented our results on lobectomy and extended lobectomy for #NSCLC at #ITSOS24 @AATSHQ: 85% VATS; 3.3% conversion; 0.1% 30-day mortality; 6.8%…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.